Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 2
2012 3
2015 3
2016 2
2017 1
2019 1
2020 6
2021 4
2022 1
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma.
Betancor YZ, Ferreiro-Pantín M, Anido-Herranz U, Fuentes-Losada M, León-Mateos L, García-Acuña SM, Vaamonde-Rodríguez V, García-Pinel B, Cebey-López V, Villaverde-Viaño R, Lombardía-Rodríguez H, Kotrulev M, Fernández-Díaz N, Gomez-Tourino I, Fernández-Baltar C, García-González J, Tubio JMC, López-López R, Ruiz-Bañobre J. Betancor YZ, et al. Among authors: leon mateos l. Front Immunol. 2024 Apr 10;15:1374728. doi: 10.3389/fimmu.2024.1374728. eCollection 2024. Front Immunol. 2024. PMID: 38660294 Free PMC article.
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.
Gómez Rueda A, Taus Á, Álvarez Álvarez R, Bernabé-Caro R, Chara L, López-Brea M, Vilà L, Sala González MÁ, Del Barrio Díaz Aldagalán A, Esteban Herrera B, López Castro R, Álvarez Cabellos R, Doménech M, Falagan S, Moreno Vega A, Aguado C, Barba A, Delgado Ureña MT, Isla D, Bellido Hernández L, Fírvida Pérez JL, Juan-Vidal Ó, Massutí B, Mielgo-Rubio X, Ortega AL, Catot S, Dómine M, Escoín-Pérez C, García Navalón F, Gil-Bazo I, Muñoz S, Rodríguez-Abreu D, Villatoro Roldán RM, Alonso-Jáudenes Curbera G, León-Mateos L, Padilla A, Paredes Lario A, Sánchez-Torres JM, Garrido P; Spanish Lung Cancer Group. Gómez Rueda A, et al. Among authors: leon mateos l. Clin Transl Oncol. 2024 Mar 21. doi: 10.1007/s12094-024-03404-9. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38512450
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
Heymach JV, Harpole D, Mitsudomi T, Taube JM, Galffy G, Hochmair M, Winder T, Zukov R, Garbaos G, Gao S, Kuroda H, Ostoros G, Tran TV, You J, Lee KY, Antonuzzo L, Papai-Szekely Z, Akamatsu H, Biswas B, Spira A, Crawford J, Le HT, Aperghis M, Doherty GJ, Mann H, Fouad TM, Reck M; AEGEAN Investigators. Heymach JV, et al. N Engl J Med. 2023 Nov 2;389(18):1672-1684. doi: 10.1056/NEJMoa2304875. Epub 2023 Oct 23. N Engl J Med. 2023. PMID: 37870974 Clinical Trial.
Top-of-the-art cytometry as a novel tool to aid in lung cancer immunotherapy.
Mondelo-Macía P, León-Mateos L, Bernardo D, Díaz-Peña R. Mondelo-Macía P, et al. Among authors: leon mateos l. Transl Lung Cancer Res. 2023 May 31;12(5):957-961. doi: 10.21037/tlcr-23-80. Epub 2023 Apr 6. Transl Lung Cancer Res. 2023. PMID: 37323174 Free PMC article. No abstract available.
Rapid Idylla mutational testing to detect EGFR mutations in plasma samples and to monitor therapy in advanced non-small cell lung cancer patients.
Mondelo-Macía P, Lago-Lestón RM, Rodríguez-Casanova A, Abalo A, Díaz-Lagares Á, García-González J, León-Mateos L, Díaz-Peña R, Muinelo-Romay L. Mondelo-Macía P, et al. Among authors: leon mateos l. Pathology. 2023 Aug;55(5):698-703. doi: 10.1016/j.pathol.2023.01.004. Epub 2023 Mar 15. Pathology. 2023. PMID: 37037720 No abstract available.
Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled Trial.
Provencio M, Ortega AL, Coves-Sarto J, Calvo V, Marsé-Fabregat R, Dómine M, Guirado M, Carcereny E, Fernández N, Álvarez R, Blanco R, León-Mateos L, Sánchez-Torres JM, Sullivan IG, Cobo M, Sánchez-Hernández A, Massuti B, Sierra-Rodero B, Mártinez-Toledo C, Serna-Blasco R, Romero A, Cruz-Bermúdez A. Provencio M, et al. Among authors: leon mateos l. JAMA Oncol. 2023 Mar 1;9(3):344-353. doi: 10.1001/jamaoncol.2022.5959. JAMA Oncol. 2023. PMID: 36520426 Free PMC article.
Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients.
Mondelo-Macía P, García-González J, Abalo A, Mosquera-Presedo M, Aguín S, Mateos M, López-López R, León-Mateos L, Muinelo-Romay L, Díaz-Peña R. Mondelo-Macía P, et al. Among authors: leon mateos l. Transl Lung Cancer Res. 2022 Oct;11(10):1995-2009. doi: 10.21037/tlcr-22-273. Transl Lung Cancer Res. 2022. PMID: 36386449 Free PMC article.
Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab.
Mondelo-Macía P, García-González J, León-Mateos L, Anido U, Aguín S, Abdulkader I, Sánchez-Ares M, Abalo A, Rodríguez-Casanova A, Díaz-Lagares Á, Lago-Lestón RM, Muinelo-Romay L, López-López R, Díaz-Peña R. Mondelo-Macía P, et al. Among authors: leon mateos l. Mol Oncol. 2021 Nov;15(11):2923-2940. doi: 10.1002/1878-0261.13094. Epub 2021 Sep 23. Mol Oncol. 2021. PMID: 34465006 Free PMC article.
Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers.
Pereira-Veiga T, González-Conde M, León-Mateos L, Piñeiro-Cid R, Abuín C, Muinelo-Romay L, Martínez-Fernández M, Brea Iglesias J, García González J, Anido U, Aguín-Losada S, Cebey V, Costa C, López-López R. Pereira-Veiga T, et al. Among authors: leon mateos l. Clin Exp Metastasis. 2021 Apr;38(2):239-251. doi: 10.1007/s10585-021-10075-1. Epub 2021 Feb 26. Clin Exp Metastasis. 2021. PMID: 33635497 Free PMC article.
29 results